Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Erhan Ararat

Concepts (104)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
11
2015
1174
1.120
 Why?
Organoids
2
2022
39
1.000
 Why?
Anti-Asthmatic Agents
1
2023
30
0.890
 Why?
Metformin
1
2023
64
0.840
 Why?
Lung
3
2022
486
0.760
 Why?
Asthma
1
2023
281
0.690
 Why?
Aspirin
2
2011
114
0.670
 Why?
Cystic Fibrosis
1
2021
147
0.660
 Why?
Diabetes Mellitus
1
2021
285
0.600
 Why?
Neoadjuvant Therapy
3
2013
114
0.470
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2011
989
0.370
 Why?
Diphosphonates
1
2010
90
0.350
 Why?
Imidazoles
1
2010
119
0.340
 Why?
Neoplasm Metastasis
1
2010
231
0.340
 Why?
Protein Phosphatase 1
1
2009
7
0.340
 Why?
Losartan
1
2009
26
0.340
 Why?
Mitogen-Activated Protein Kinase 3
1
2009
50
0.330
 Why?
Mitogen-Activated Protein Kinase 1
1
2009
51
0.330
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2010
121
0.330
 Why?
Angiotensin II Type 1 Receptor Blockers
1
2009
43
0.330
 Why?
Isoenzymes
1
2009
168
0.320
 Why?
MAP Kinase Signaling System
1
2009
119
0.320
 Why?
Adolescent
4
2024
6356
0.310
 Why?
Genetic Predisposition to Disease
1
2011
510
0.300
 Why?
Child
3
2024
6847
0.280
 Why?
Antineoplastic Agents
2
2011
1171
0.260
 Why?
Humans
19
2024
49974
0.250
 Why?
Adrenal Cortex Hormones
1
2023
94
0.210
 Why?
Preoperative Care
1
2024
164
0.210
 Why?
Home Care Services
1
2023
73
0.210
 Why?
Spinocerebellar Ataxias
1
2022
4
0.210
 Why?
Female
14
2024
26472
0.200
 Why?
Young Adult
4
2023
3958
0.190
 Why?
Body Height
1
2021
65
0.190
 Why?
Respiration, Artificial
1
2023
274
0.190
 Why?
Mass Screening
1
2024
353
0.190
 Why?
Anthracyclines
2
2011
27
0.180
 Why?
Disease Progression
1
2023
825
0.180
 Why?
Nutritional Status
1
2021
141
0.180
 Why?
Incidence
2
2011
1003
0.150
 Why?
Adult
5
2023
13236
0.130
 Why?
Multiple Myeloma
1
2010
2929
0.130
 Why?
Muscular Dystrophy, Duchenne
1
2015
18
0.130
 Why?
Receptors, Progesterone
2
2013
63
0.120
 Why?
Cardiomyopathies
1
2015
108
0.120
 Why?
Receptor, erbB-2
2
2013
73
0.120
 Why?
Receptors, Estrogen
2
2013
130
0.110
 Why?
Retrospective Studies
3
2021
6108
0.110
 Why?
Axilla
1
2013
89
0.110
 Why?
Prognosis
3
2015
1942
0.110
 Why?
Child, Preschool
1
2021
3871
0.110
 Why?
Heart
1
2015
326
0.110
 Why?
Phenotype
1
2015
729
0.100
 Why?
Lymphatic Metastasis
1
2013
224
0.100
 Why?
Survival Rate
2
2013
894
0.100
 Why?
Dacarbazine
1
2011
9
0.100
 Why?
Opportunistic Infections
1
2011
58
0.100
 Why?
Deoxycytidine
1
2011
27
0.100
 Why?
Lymph Nodes
1
2013
260
0.100
 Why?
Antineoplastic Agents, Alkylating
1
2011
74
0.100
 Why?
Fluorouracil
1
2011
54
0.100
 Why?
Genes, BRCA1
1
2011
19
0.090
 Why?
Phthalazines
1
2011
20
0.090
 Why?
Drugs, Generic
1
2010
6
0.090
 Why?
Male
4
2024
25241
0.090
 Why?
Neoplasm Recurrence, Local
2
2013
614
0.090
 Why?
Taxoids
1
2010
37
0.090
 Why?
Antineoplastic Agents, Hormonal
1
2010
47
0.090
 Why?
Tamoxifen
1
2010
60
0.090
 Why?
Piperazines
1
2011
117
0.090
 Why?
Captopril
1
2009
12
0.080
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2009
65
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
96
0.080
 Why?
Chemotherapy, Adjuvant
3
2015
119
0.080
 Why?
Enzyme Activation
1
2009
276
0.080
 Why?
Muscle, Smooth, Vascular
1
2009
130
0.080
 Why?
Aorta
1
2009
161
0.080
 Why?
Ventricular Function, Left
1
2009
154
0.080
 Why?
Age Factors
1
2011
1087
0.070
 Why?
Follow-Up Studies
1
2011
2182
0.060
 Why?
Myocardial Infarction
1
2009
389
0.060
 Why?
Rats, Sprague-Dawley
1
2009
1597
0.060
 Why?
Apoptosis
1
2010
1101
0.060
 Why?
Mutation
1
2011
1294
0.060
 Why?
Treatment Outcome
2
2013
5141
0.060
 Why?
Heart Failure
1
2009
458
0.060
 Why?
Respiration
1
2023
97
0.060
 Why?
Tracheostomy
1
2023
75
0.050
 Why?
Rats
1
2009
3305
0.050
 Why?
Stem Cells
1
2022
171
0.050
 Why?
Animals
2
2022
13187
0.050
 Why?
Epithelial Cells
1
2022
209
0.050
 Why?
Cell Differentiation
1
2022
651
0.040
 Why?
Respiratory Function Tests
1
2015
90
0.030
 Why?
Aged
3
2013
9310
0.030
 Why?
Neoplasm Invasiveness
1
2013
267
0.030
 Why?
Disease-Free Survival
1
2013
454
0.030
 Why?
Mice
1
2022
5739
0.020
 Why?
Chemistry, Pharmaceutical
1
2010
32
0.020
 Why?
Arthralgia
1
2010
43
0.020
 Why?
Drug Administration Schedule
1
2010
376
0.020
 Why?
Middle Aged
2
2013
12069
0.020
 Why?
Risk Factors
1
2015
3613
0.020
 Why?
Aged, 80 and over
1
2013
3129
0.020
 Why?
Ararat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (104) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department